Why Latin American stocks are attractive right now

Low valuations and soaring commodity prices have boosted Latin American stocks this year. Alex Rankine looks at why the region is lucrative right now.

Jair Bolsonaro
Brazil fell into a severe recession in the middle of the 2010s.
(Image credit: © Getty)

Latin America is proving “a darling destination for investors in 2022”, say Anisha Sircar and Rodrigo Campos for Reuters. Low valuations and soaring commodity prices have given the region’s stocks a boost. Currencies in Brazil, Colombia, Peru and Chile are the “four best-performing across emerging markets against the dollar” so far this year.

Stronger local currencies help flatter gains for foreign investors. The MSCI Emerging Markets Latin America (LatAm) index has gained 25% in dollar terms year-to-date, even as the broader MSCI Emerging Markets (EM) index has dropped 8%.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Markets editor

Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019. 

Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere. 

He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful. 

Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.